Immunome Inc
NASDAQ:IMNM 4:00:00 PM EDT
| Market Cap (Intraday) | 1.04B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $19.79 |
| 50-Day MA | $23.11 |
| 200-Day MA | $12.44 |
Immunome Inc Stock, NASDAQ:IMNM
18702 North Creek Parkway, Suite 100, Bothell, Washington 98011
United States of America
Phone: +1.610.321.3700
Number of Employees: 55
Description
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.